Risk Factors of Ventilator-Associated Pneumonia in Critically Ill Population of Alexandria

NCT ID: NCT07116382

Last Updated: 2025-08-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

180 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-02-20

Study Completion Date

2025-05-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to compare cases of ventilator-associated pneumonia with matched controls of mechanically ventilated patients to identify any relevant independent risk factors for ventilator-associated pneumonia. All adult (≥ 18 years) mechanically ventilated patients \> 48 hours who are diagnosed with ventilator-associated pneumonia are considered as cases. The control group are mechanically ventilated patients and matching with cases regarding their age, gender, and duration of mechanical ventilation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Ventilator-associated pneumonia is associated with long hospital stays and significant costs. It also prolongs the length of mechanical ventilation. Incidences of ventilator associated pneumonia are highly influenced by the characteristics of the patient population studied and the criteria and techniques applied for diagnosis. The reported incidence is ranged between 10-20% of mechanically ventilated patients. This incidence in developed countries differs significantly from that in developing ones due to many reasons. Several risk factors are identified. The risk factors can be host, device, or personnel related. The most reproducible risk factor is the duration of mechanical ventilation.

The most well recognized modifiable risk factors are mainly intervention related causes. Despite widespread ventilator-associated pneumonia prevention efforts, there was a 35% increase in the ventilator associated events between 2019 and 2020. Since critically ill patients are dynamic patients who are in need to multiple interventions and techniques, revisiting the risk factors of VAP is essential.

Despite widespread prevention efforts, VAP prevention bundles, surveillance systems and updating definitions by CDC, there was a 35% increase in the ventilator associated events between 2019 and 2020 according to CDC healthcare associated infections progress report in 2020. Since critically ill patients are dynamic patients who are in need to multiple interventions and techniques, revisiting the modifiable risk factors of VAP is essential.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ventilator Associated Pneumonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

VAP group

All adult (≥ 18 years) mechanically ventilated patients \> 48 hours who are diagnosed with ventilator-associated pneumonia are considered as cases. All possible risk factors for VAP are investigated.

No interventions assigned to this group

Matched Control group

Mechanically ventilated (≥ 48 hours) patients and matching with cases regarding their age, gender, and duration of MV. All possible risk factors for VAP are investigated.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All adult (≥ 18 years) mechanically ventilated patients \> 48 hours who are diagnosed with VAP (Case Group).
* The control group is mechanically ventilated (≥ 48 hours) patients and matched with cases regarding their gender, age, and duration of MV.

Exclusion Criteria

* Patients with pneumonia prior to MV and those developing pneumonia within 48 hours are excluded from the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Suez Canal University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

islam elsayed

Researcher, Public Health and Community Medicine Department

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AMUH

Alexandria, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VAPRISK

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.